TY - JOUR T1 - Computational analysis of pathological image enables interpretable prediction for microsatellite instability JF - medRxiv DO - 10.1101/2020.12.07.20244616 SP - 2020.12.07.20244616 AU - Jin Zhu AU - Wangwei Wu AU - Yuting Zhang AU - Shiyun Lin AU - Yukang Jiang AU - Ruixian Liu AU - Xueqin Wang AU - Heping Zhang Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/12/08/2020.12.07.20244616.abstract N2 - Objective Microsatellite instability (MSI) is associated with several tumor types and its status has become increasingly vital in guiding patient treatment decisions. However, in clinical practice, distinguishing MSI from its counterpart is challenging since the diagnosis of MSI requires additional genetic or immunohistochemical tests. In this study, we aimed to establishe an interpretable pathological image analysis strategies to help medical experts to identify MSI automatically.Design Three cohorts of Haematoxylin and eosin-stained whole-slide images from 1033 patients with different tumor types were collected from The Cancer Genome Atlas. These images were preprocessed and tessallated into small tiles. A image-level interpretable deep learning model and a feature-level interpretable random forest model were built up on these files.Results Both models performed well in the three datasets and achieved image-level and feature-level interpretability repectively. Importantly, both from the image-level and feature-level interpretability, color features and texture characteristics are shown to contribute the most to the MSI prediction. Based on them, we established an interpretable classification framework. Therefore, the classification models under the proposed framework can serve as an efficient tool for predicting the MSI status of patients.Conclusion This study establishes a interpretable classification framework to for predicting the MSI status of patients and provide more insights to pathologists with clinical understanding.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received in this studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research involves analysis of de-identified data initially collected by The Cancer Genome Atlas Program. The Institutional Review Board of Sun Yat-sen University reviewed this research and found that it is exempt since the research does not involve identifiable private information.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData, models, or code generated or used during the study are available in a repository in accordance with funder data retention policies. ER -